From: Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases
Case reports/series | Neurological manifestations | Presence of additional irAEs |
---|---|---|
Wilgenhof S, et al. (2011) [23] | Guillain-Barré Syndrome | None reported |
Bompaire F, et al. (2012) [18] | Meningo-radiculo-neuritis | None reported |
Bot I, et al. (2013) [21] (n = 3) | Hypophysitis Meningitis Guillain-Barré syndrome | |
Liao B. et al. (2014) [21] (n = 3) | CIDP Transverse myelitis Myasthenia gravis-type syndrome | None reported |
Johnson DB, et al. (2015) [24] | Myasthenia gravis | Thyroiditis Dermatitis |
Thaipisuttikul I, et al.(2015) [35] | Peripheral neuropathy | None reported |
Abdallah AO, et al. (2016) [31] | Necrotic myelopathy | None reported |
Chen JH, et al. (2017) [27] | Myasthenia gravis | Myositis Polyneuropathy Hepatitis |
Derle E, et al. (2018) [25] | Myasthenia gravis | None reported |
Montes V, et al. (2018) [26] | Myasthenia gravis | None reported |
Naito T, et al. (2018) [22] | Acute cerebellitis | None reported |
Ruff MW, et al. (2018) [28] (n = 2) | Bilateral phrenic nerve paralysis Bell’s palsy | Pan-hypopituitarism |